Avelumab for metastatic Merkel cell carcinoma after chemotherapy

Dr Kaufman presents results at AACR 2017 of a trial administering avelumab to patients with advanced Merkel cell carcinoma who had not responded to chemotherapy. Slides from this presentation are available here, and you can read more about the results...

from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2osTpBu
via IFTTT